Ideas to Action:

Independent research for global prosperity

Views from the Center

CGD experts offer ideas and analysis to improve international development policy. Also check out our Global Health blog and US Development Policy blog.

 

Visualization breaking down where most aid goes

Focusing UK Research Aid Where It Matters

The UK’s development agency, DFID, has stated that it views research as the best way to spend aid and that it intends to place high quality research central to its aid strategy. In a new paper, we find significant problems with the way that UK aid is being used to back research: a huge ramp-up in support has largely gone to fund opaque, unfocused research in UK universities. There are better approaches.

The UK Needs a New Formula for ODA-Funded Research

The UK government has recently ramped up the amount of aid that is directed towards research and development. While this can be positive in ensuring a sound research base for UK aid funds, this should not be seen as an opportunity to plug UK university funding deficits, or to "tie aid" to the UK economy.

A woman working with a laptop and notebook. Adobe Stock.

To Build Stronger Research Institutions in Sub-Saharan Africa, We Need Your Help

The ideas that will lead to sustained, transformative change in Africa must and will come from Africans in Africa. Central to this is the building of Africa-led, Africa-based institutions capable of producing research that responds to local needs. Yet, despite decades of global investment targeted at building capacity in African institutions, sub-Saharan Africa (SSA) continues to lag behind all other global regions on key research metrics, including overall institutional rating, research outputs, and trained personnel.

A nurse at Merawi health centre in northern Ethiopia prepares a measles vaccine for delivery.

We Asked, You Answered: Reflections on the First Round of MVAC Feedback

In March, our team at the Center for Global Development and Office of Health Economics posted a consultation draft of a policy proposal for a Market-Driven, Value-Based Advanced Commitment (MVAC). The MVAC is a new mechanism that puts middle-income country governments in the driver’s seat to accelerate R&D for diseases that affect the world’s poor—specifically, the 10 million men, women, and children who develop tuberculosis (TB) disease each year and desperately need better therapies. 

For a Clean Energy Breakthrough to Save the Planet, It Cannot Forget the Developing World

Most people accept that we will only achieve sustainable energy patterns with a substantial investment in research and development, but where the research will take place and where energy will be consumed doesn’t necessarily match up. Within 25 years, non-OECD countries will account for two-thirds of global energy consumption. To that end, the climate and energy challenge is primarily about finding ways to bring clean energy to Rio and Lagos, not to San Francisco or Berlin. 

Should Development RCTs Be Blind? Not So Fast

Proponents of the use of randomized controlled trials (RCTs) in impact evaluation and development research often point out the close link between these trials and their clinical counterparts in the world of medical research.